Close Menu
    Zukunftsforschung

    Die GLP-1-Behandlung zur Gewichtsreduktion wird bei Alkohol- und Drogenabhängigkeit eingesetzt

    Share.
    View 5 Comments

    5 Kommentare

    1. Successful-Peach-764 on

      GLP-1 receptor agonists, originally designed for diabetes and weight loss, are showing transformative potential for future addiction treatment, especially for alcohol and other substance use disorders. Early research, including both animal models and human clinical trials, indicates that these drugs may significantly reduce substance cravings, one study showed a 40% reduction in opioid cravings among patients taking GLP-1 drugs, which is comparable to reductions seen in intensive addiction treatments.

      This could in the future be a key weapon in addressing the global addiction crisis which suffers from a persistent lack of effective treatment options. Less than a quarter of people with substance use disorders receive treatment and a key problem is limited availability of therapies.

    2. NU1_L1F1ED on

      The wide applicability of GLP-1 receptor agonists is unprecedented in medicine. From weight loss to disease prevention and protective properties, and now a possible agent to help with the opioid crisis and addiction. Truly amazing!

      In my personal experience, I’m two months in to using a GLP-1 for weight loss and I’ve never felt better. It’s helped me lose enough weight in that time frame to get me back in the gym with less stress on my joints, further increasing my capacity to take back control over my health.

    4. weirdkid71 on

      Now if only more health insurances would cover it. I’m paying out of pocket for it because my insurance would only cover it *after* a type 2 diabetes diagnosis. I figured it’s worth the $500 per month to offset larger health issues caused by my weight later on in life. In the long run, I’m saving my insurance company money by taking these meds, but they don’t see it that way.

    Leave A Reply